320 related articles for article (PubMed ID: 11727259)
21. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
[TBL] [Abstract][Full Text] [Related]
22. The Brenner tumor: a clinicopathologic review.
Balasa RW; Adcock LL; Prem KA; Dehner LP
Obstet Gynecol; 1977 Jul; 50(1):120-8. PubMed ID: 195239
[TBL] [Abstract][Full Text] [Related]
23. Borderline Brenner Tumor of the Ovary Coexisting With an Ovarian Mucinous Cystadenoma With Focal Atypical Epithelial Proliferation: A Rare Case With Review of the Literature.
Salibay CJ; Zanfagnin V; Miller H; Walia S; Brunette LL; Wang T
Int J Surg Pathol; 2021 Oct; 29(7):788-793. PubMed ID: 33635096
[TBL] [Abstract][Full Text] [Related]
24. Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma.
Ylisaukko-oja SK; Cybulski C; Lehtonen R; Kiuru M; Matyjasik J; Szymañska A; Szymañska-Pasternak J; Dyrskjot L; Butzow R; Orntoft TF; Launonen V; Lubiñski J; Aaltonen LA
Eur J Hum Genet; 2006 Jul; 14(7):880-3. PubMed ID: 16639410
[TBL] [Abstract][Full Text] [Related]
25. Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms: High Variant Concordance and Identification of Mutually Exclusive RAS Driver Mutations and MYC Amplification.
Tafe LJ; Muller KE; Ananda G; Mitchell T; Spotlow V; Patterson SE; Tsongalis GJ; Mockus SM
Am J Pathol; 2016 Mar; 186(3):671-7. PubMed ID: 26797085
[TBL] [Abstract][Full Text] [Related]
26. [Mucinous tumors of the ovary. Anatomo-clinical aspects, histological classification, prognostic factors and histogenesis].
Bouzourene H; Genton CY
Arch Anat Cytol Pathol; 1997; 45(4):192-8. PubMed ID: 9406476
[TBL] [Abstract][Full Text] [Related]
27. [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
Luchian AM; Pricop M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):438-45. PubMed ID: 21870737
[TBL] [Abstract][Full Text] [Related]
28. Mucinous tumors of the ovary: a review.
Hart WR
Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
30. [Studies on the point mutation of ras oncogene in ovarian tumor].
Fujimoto I; Shimizu Y; Umezawa S; Katase K; Hirai Y; Yamauchi K; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1289-96. PubMed ID: 8258728
[TBL] [Abstract][Full Text] [Related]
31. Well-differentiated mucinous carcinoma of the ovary and a coexisting Brenner tumor both exhibit amplification of 12q14-21 by comparative genomic hybridization.
Pejovic T; Bürki N; Odunsi K; Fiedler P; Achong N; Schwartz PE; Ward DC
Gynecol Oncol; 1999 Jul; 74(1):134-7. PubMed ID: 10385566
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
33. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
[TBL] [Abstract][Full Text] [Related]
34. Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes.
Sekizawa A; Amemiya S; Otsuka J; Saito H; Farina A; Okai T; Tachikawa T
Med Electron Microsc; 2004 Jun; 37(2):97-100. PubMed ID: 15221651
[TBL] [Abstract][Full Text] [Related]
35. Ovarian Combined Brenner Tumor, Mucinous Cystadenoma and Struma Ovarii: First Report of a Rare Combination.
Sah S; McCluggage WG
Int J Gynecol Pathol; 2019 Nov; 38(6):576-580. PubMed ID: 30134344
[TBL] [Abstract][Full Text] [Related]
36. Huge primary retroperitoneal mucinous cystadenoma of borderline malignancy mimicking an ovarian mass: case report and review.
Bifulco G; Mandato VD; Giampaolino P; Nappi C; De Cecio R; Insabato L; Tarsitano F; Mignogna C
Anticancer Res; 2008; 28(4C):2309-15. PubMed ID: 18751411
[TBL] [Abstract][Full Text] [Related]
37. [Accuracy of frozen section in diagnosis of ovarian tumors].
Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):601-3, 635. PubMed ID: 8112130
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetic evidence supporting the neoplastic nature of the Leydig cell component of ovarian Sertoli-Leydig cell tumors.
Emerson RE; Wang M; Roth LM; Zheng W; Abdul-Karim FW; Liu F; Ulbright TM; Eble JN; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):368-74. PubMed ID: 17885485
[TBL] [Abstract][Full Text] [Related]
39. Primary retroperitoneal mucinous tumors: a clinicopathologic study of 18 cases.
Roma AA; Malpica A
Am J Surg Pathol; 2009 Apr; 33(4):526-33. PubMed ID: 19092632
[TBL] [Abstract][Full Text] [Related]
40. [Borderline ovarian tumors and global radiation in relation with climate change impact].
Luchian AM; Pricop M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):813-9. PubMed ID: 22046792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]